Serum microRNA-92 expression in patients with ovarian epithelial carcinoma

Journal of International Medical Research

Volumn 41, Issue 5, 2013, Pages 1456-1461

  Guo, Fengjun ^a   Tian, Jingyan ^a   Lin, Yang ^a   Jin, Yuemei ^a   Wang, Ling ^a   Cui, Manhua ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

clinical stage; microRNA 92; miR 92; ovarian epithelial carcinoma; regional lymph node involvement; serum; tumour marker

Indexed keywords

MICRORNA; MICRORNA 92; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BLOOD LEVEL; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LYMPH NODE METASTASIS; OVARIAN EPITHELIAL CARCINOMA; OVARY CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC;

CLINICAL STAGE; MICRORNA-92; MIR-92; OVARIAN EPITHELIAL CARCINOMA; REGIONAL LYMPH NODE INVOLVEMENT; SERUM; TUMOUR MARKER;

CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIKELIHOOD FUNCTIONS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84887266150     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513487652     Document Type: Article

References (24)

1. Djordjevic B,Stojanovic S,Conic I, et al.Current approach to epithelial ovarian cancer based on the concept of cancer stem cells.J BUON. 2012;17:627-636.
2. Auersperg N,Wong AS,Choi KC, et al.Ovarian surface epithelium: biology, endocrinology, and pathology.Endocr Rev. 2001;22:255-288.
3. Hong F,Li Y,Xu Y, et al.Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.J Int Med Res. 2013;41:64-71.
4. Ambros V.The functions of animal microRNAs.Nature. 2004;431:350-355.
5. Zamore PD,Haley B.Ribo-gnome: The big world of small RNAs.Science. 2005;309:1519-1524.
6. Meister G.miRNAs get an early start on translational silencing.Cell. 2007;131:25-28.
7. Calin GA,Liu CG,Sevignani C, et al.MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.Proc Natl Acad Sci U S A. 2004;101:11755-11760.
8. Iorio MV,Ferracin M,Liu CG, et al.MicroRNA gene expression deregulation in human breast cancer.Cancer Res. 2005;65:7065-7070.
9. Murakami Y,Yasuda T,Saigo K, et al.Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.Oncogene. 2006;25:2537-2545.
10. Yanaihara N,Caplen N,Bowman E, et al.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.Cancer Cell. 2006;9:189-198.
11. Lou YH,Yang XS,Wang FL, et al.[Expression of microRNA-21 in ovarian epithelial carcinoma and its clinical significance].Nan Fang Yi Ke Da Xue Xue Bao. 2010;30:608-613.
12. Zhu S,Si ML,Wu H, et al.MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).J Biol Chem. 2007;282:14328-14336.
13. Volinia S,Calin GA,Liu CG, et al.A microRNA expression signature of human solid tumors defines cancer gene targets.Proc Natl Acad Sci U S A. 2006;103:2257-2261.
14. Tran N,McLean T,Zhang X, et al.MicroRNA expression profiles in head and neck cancer cell lines.Biochem Biophys Res Commun. 2007;358:12-17.
15. Sobin LH,Wittekind CInternational Union Against Cancer: TNM classification of malignant tumors. 5th edn. New York: Wiley, 1997.New York: Wiley; 1997:.
16. Kroh EM,Parkin RK,Mitchell PS, et al.Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR(qRT-PCR).Methods. 2010;50:298-301.
17. Chim SS,Shing TK,Hung EC, et al.Detection and characterization of placental microRNAs in maternal plasma.Clin Chem. 2008;54:482-490.
18. Davidson-Moncada J,Papavasiliou FN,Tam W.MicroRNAs of the immune system: roles in inflammation and cancer.Ann N Y Acad Sci. 2010;1183:183-194.
19. Liston A,Linterman M,Lu LF.MicroRNA in the adaptive immune system, in sickness and in health.J Clin Immunol. 2010;30:339-346.
20. Calin GA,Ferracin M,Cimmino A, et al.A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.N Engl J Med. 2005;353:1793-1801.
21. Chen X,Ba Y,Ma L, et al.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.Cell Res. 2008;18:997-1006.
22. Ng EK,Chong WW,Jin H, et al.Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.Gut. 2009;58:1375-1381.
23. Taylor DD,Gercel-Taylor C.MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.Gynecol Oncol. 2008;110:13-21.
24. Resnick KE,Alder H,Hagan JP, et al.The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.Gynecol Oncol. 2009;112:55-59.